Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05493306
Other study ID # 0002 Evaluation Telereha
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 8, 2021
Est. completion date June 30, 2022

Study information

Verified date July 2022
Source Pensionsversicherungsanstalt
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Telerehabilitation is implemented in the Pensionsversicherungsanstalt (PVA) as an independent rehabilitation offer following a rehabilitation phase II. This offer primarily includes physiotherapeutic training units in group settings and in individual counselling, as well as health-related educational sessions and doctor's consultations via video conferencing, initially for rehabilitation patients with diseases of the musculoskeletal system or oncological diseases. The first stage of the implementation process was evaluated with a focus on acceptance, usability and feasibility from the perspective of patients and treatment team. The evaluation was based on a convergent mixed methods design (Creswell & Plano Clark, 2017) to draw on the strengths of qualitative and quantitative research approaches (Creswell & Creswell, 2018). Qualitative and quantitative data were generated in parallel and treated equally. The perspective of the patients (N = 86) was collected through online questionnaires and in-depth telephone interviews (N = 22) and that of the treatment team through a questionnaire survey (N = 32) and focus group interviews (N = 24). The administrative team (N = 8) was asked for their assessment in a focus group interview. Technical difficulties in the implementation of telerehabilitation were documented by the treatment team. The consolidation of these multi-perspective results took place at the level of interpretation.


Recruitment information / eligibility

Status Completed
Enrollment 126
Est. completion date June 30, 2022
Est. primary completion date March 31, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: Patients who have completed rehabilitation (phase II) with the indications: - musculoskeletal diseases - oncology. Exclusion Criteria: - Failure to obtain the declaration of consent - Lack of the required technical aids (mobile phone, tablet or PC) - Lack of the technical skills to operate the app and thus to participate in telerehabilitation.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Austria PVA - Zentrum für ambulante Rehabilitation Graz Graz Styria

Sponsors (1)

Lead Sponsor Collaborator
Pensionsversicherungsanstalt

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Usability of the telerehabilitation The patients' perspective was collected with a self-developed online questionnaire (N = 86) and in-depth telephone interviews (N = 22).
The questionnaires were analysed descriptively. The telephone interviews were protocolled and subsequently coded and categorised.
The perspective of the treatment team was collected with a self-developed questionnaire (N = 32) and focus group interviews (N = 24).
In addition, the administrative team (N = 8) was asked for their assessments in a focus group interview. The questionnaires were analysed descriptively. The focus group interview was recorded and subsequently coded and categorised.
April 2021 - May 2022
Primary Feasibility of the telerehabilitation Technical difficulties concerning the video calls were continuously documented by the treatment team. The data were analysed descriptively. April 2021 - May 2022
Primary Acceptance of the telerehabilitation The patients' perspective was collected with a self-developed online questionnaire (N = 86) and in-depth telephone interviews (N = 22).
The questionnaires were analysed descriptively. The telephone interviews were protocolled and subsequently coded and categorised.
The perspective of the treatment team was collected with a self-developed questionnaire (N = 32) and focus group interviews (N = 24).
The questionnaires were analysed descriptively. The focus group interviews were recorded and subsequently coded and categorised.
April 2021 - May 2022
See also
  Status Clinical Trial Phase
Completed NCT01439152 - Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors. Phase 1
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Active, not recruiting NCT06015009 - Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers N/A
Active, not recruiting NCT03298100 - Risk Scoring Model for Endometrial Cancer
Recruiting NCT05055609 - Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors Phase 1
Not yet recruiting NCT04324320 - Psychological Distress in Outpatient Oncological Rehabilitation
Completed NCT00588289 - Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA N/A
Recruiting NCT06222801 - The 1st Tumor CytokinoTherapy Database (TCTD-1)
Recruiting NCT03831633 - Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients Phase 4
Completed NCT04914702 - Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Recruiting NCT05198570 - Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
Recruiting NCT05712174 - A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer Phase 2
Recruiting NCT03832062 - Value of Analysing Under-utilised Leftover Tissue (VauLT)
Completed NCT03988777 - Magnetic Seed Localisation for Nonpalpable Breast Lesions
Recruiting NCT06031233 - Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie Phase 4
Enrolling by invitation NCT04019119 - Digital Intervention for the Modification of Lifestyles (iGame) N/A
Not yet recruiting NCT05926362 - Capillary-Venous Paired Data Collection
Recruiting NCT05686213 - ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial Phase 2
Recruiting NCT05510856 - Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients Phase 4
Completed NCT04933604 - LPN in Patients With High-complex Renal Tumors